Brachytherapy / Internal Radiation

What is High Dose Rate (HDR) Brachytherapy?

HDR afterloader brachytherapy is an exciting technological advance which allows to treat cancerous tissues with PRECISION HIGH DOSE in SHORT time, and less radiation to healthy tissues ? Therefore, better chance to control cancer with less injury to healthy organs.

How is HDR brachytherapy performed?

This afterloader unit contains a high activity radiation source (Iridium?192), housed within a shielded compartment. Unloaded (blank) applicators are positioned in the patient and are connected to the unit with pliable hollow tubes. The radiation source is loaded into the applicator via the hollow tubes, by a remote control. Computerized safety checks insure proper positioning of the sources and safe delivery of radiation. The applicator is removed after the radiation delivery is completed.

What are the advantages of HDR brachytherapy?

  1. Out-patient based treatments
  2. Patient comfort
  3. Short treatment time
  4. Minimal side effects during the procedure
  5. Minimal recovery time -
  6. More precise, optimized radiation dose
  7. Highly reproducible
  8. Lessened patient anxiety
  9. Eliminates radiation exposure to the personnel/staff
  10. Patient can go home with no special precautions of radiation safety Conventional brachytherapy procedures on the other hand require prolonged hospitalization (3 days or more), in an isolated room, restricted to bed with special radiation precautions and associated with anxiety.

How long has brachytherapy been in use and what does High Dose Rate Brachytherapy mean?

Shortly after Marie and Pierre Curie discovered radium in 1898, Brachytherapy was first performed successfully to treat skin cancer on the face, by directly applying radioactive material to the affected site. Low Dose Rate brachytherapy typically required 40-70 hours of therapy, prolonged hospitalization and strict bed rest. In contrast, High Dose Rate brachytherapy delivers very high dose in a few minutes.

What are the indications for HDR brachytherapy treatment ?

Cancers of the breast, head and neck, uterus, cervix, vagina, genitourinary sites, soft tissues, pediatric, lung, esophagus, trachea, bile duct, brain, skin etc.

 

Bone Cancer
Bone Metastasis
Cancer of Unknown Primary
Ewing's Sarcoma
Kaposi's Sarcoma
Metastatic
Multiple Myeloma
Myelodyspastic Syndrome
Osteosarcoma
Pituitary Tumors (Usually not cancer)
Retinoblastoma
Rhabdomyosarcoma
Sarcoma (Adult Sot Tissue Sarcoma)
Thymus Cancer
Hodgkins' Lymphoma
Non-Hodgkins' Lymphoma
Leukemia(Adult Acute)
Leukemia(Adult Chronic)
Eye
Hypopharynx
Larynx / Vocal cord
Nasopharyngeal
Oral Cavity / Tongue
Oropharynx
Orbit
Salivary gland
Sinuses
Thyroid
Cervical
Uterus / Endometrium
Uterine Sarcoma
Ovary
Vagina
Vulvar
Gestational Trophoblastic Disease
Melanoma
Non-melanoma
Brain and Central Nervous System
Hodgkins Disease
Non - Hodgkins' Lymphoma
Leukemias
Rhabdomyosarcoma
Ewings sarcoma
Neuroblastoma
Retinoblastoma
Wilm's Tumor
Stomach
Pancreas
Gall Bladder
Bile Duct
Colon
Rectum
Anal Canal
Carcinoid
Liver
Thymus
Mediastinum
Malignant Mesothelioma of Pleura
Espohagus
Brain / Central Nervous System
Spinal cord
Children
Prostate
Penile
Bladder
Testis
Kidney / Ureter
Female Breast
Male Breast
Conventional / Standard EBRT
Total Body Irradiation
Total Skin Electron Beam
Low dose rate brachytherapy
High dose rate brachytherapy
Systemic Radiation
Address: Department of Radiation Medicine, Zalmen A. Arlin Cancer Institute, Westchester Medical Center, 95 Grasslands Road, Valhalla, NY 10595, Phone: 914-493-8561, Email: info@cancerdocs-radiation.com